Who founded TILT Biotherapeutics Oy?

TILT Biotherapeutics Oy was founded by Akseli Hemminki in 2013.

Who are TILT Biotherapeutics Oy's investors?

TILT Biotherapeutics Oy's investors include Lifeline Ventures, Amadeus Capital Partners, Tesi (Finnish Industry Investment Ltd).

How much funding has TILT Biotherapeutics Oy raised?

TILT Biotherapeutics Oy has disclosed $25M raised across 1 round.

Where is TILT Biotherapeutics Oy headquartered?

TILT Biotherapeutics Oy is headquartered in Helsinki, FI.

TILT Biotherapeutics Oy

Helsinki, FI · Founded 2013 · 27 employees on LinkedIn · 3 known investors

Find your way into TILT Biotherapeutics Oy

Paths you didn't know you had: your email and LinkedIn already hold routes to the TILT Biotherapeutics Oy team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

TILT Biotherapeutics develops an investigational adenoviral immunotherapy platform for treating solid tumor cancers, with late-stage development of TILT-123 for head and neck cancer treatment. The company operates as a holding structure with distinct spin-out entities focused on clinical development and preclinical research.

Biotech Healthtech Medical Devices

Founders & leadership

TILT Biotherapeutics Oy was founded in 2013 by Akseli Hemminki.

Akseli HemminkiFounder and CEOFounder and CEO at Tiltbio

Investors · 3

Lifeline Ventures✓ confirmed by TILT Biotherapeutics OyHelsinki

How we know: Lifeline Ventures's portfolio page · the company's own site · a partner's Signal profile · the VCSheet dataset · Not right? Tell us

Amadeus Capital PartnersreportedLondon · $50K – $12.7M

How we know: a partner's Signal profile · Not right? Tell us

Tesi (Finnish Industry Investment Ltd)reportedHelsinki · $5.4M – $16.2M

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Funding

SEC filings, press & company announcements

$25M disclosed across 1 round · 2025

$25MSeries BMay 2025 · 2 sources
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 1

SoluSolu Therapeutics is a clinical-stage biotech developing a class of antibody therapeutics that link bifunctional small molecules to proprietary effector antibodies (its CyTAC and TicTAC platforms) to reach cell surface targets like GPCRs and ion channels. Its pipeline targets oncology, immunology and inflammation, and pain, with a lead program in Phase 1 trials for chronic myelomonocytic leukemia.

Companies working in the same space as TILT Biotherapeutics Oy.

Frequently asked questions

What does TILT Biotherapeutics Oy do?: TILT Biotherapeutics develops an investigational adenoviral immunotherapy platform for treating solid tumor cancers, with late-stage development of TILT-123 for head and neck cancer treatment. The company operates as a holding structure with distinct spin-out entities focused on clinical development and preclinical research.
Who founded TILT Biotherapeutics Oy?: TILT Biotherapeutics Oy was founded by Akseli Hemminki in 2013.
Who are TILT Biotherapeutics Oy's investors?: TILT Biotherapeutics Oy's investors include Lifeline Ventures, Amadeus Capital Partners, Tesi (Finnish Industry Investment Ltd).
How much funding has TILT Biotherapeutics Oy raised?: TILT Biotherapeutics Oy has disclosed $25M raised across 1 round.
Where is TILT Biotherapeutics Oy headquartered?: TILT Biotherapeutics Oy is headquartered in Helsinki, FI.